ArticleScientific reports2026
24-hour urine chemistry shows higher stone formation risk after malabsorptive than restrictive type bariatric surgery.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Obesity, Metabolic Syndrome, Diabetes and Kidney Stones: Strengthening Links Over Time?TouchREVIEWS in endocrinology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bariatric surgery is effective for obesity management but associated with kidney stone formation. Give the different post-operative physiology between restrictive type and malabsorptive type bariatric surgery, this study aims to compare difference in post-operative lithogenic risk profiles between these surgical types by assessing the postoperative 24-hour urine chemistry profiles. We conducted a prospective cross-sectional study of consecutive adults undergoing bariatric surgery at a tertiary center in Hong Kong between April 2017 and October 2019. A total number of 35 patients underwent malabsorptive and 55 underwent restrictive procedures. Baseline demographics, comorbidities, and postoperative 24-hour urine chemistry were assessed within 12 months after surgery. Abnormal urinary parameters were identified, with between-group comparisons performed using Mann-Whitney U and Chi-squared tests. Propensity scores were estimated using selected covariates, and stabilized inverse probability of treatment weighting (IPTW) was applied. IPTW-weighted logistic regression was used to compare the odds of abnormal urinary parameters between surgical groups. At 12 months, the malabsorptive group demonstrated significantly higher urinary oxalate and lower urinary creatinine, potassium, calcium, magnesium, citrate, urate, pH, and calcium phosphate activity compared with the restrictive group. The prevalence of hyperoxaluria (51.4% vs. 25.5%, p = 0.012), hypocitraturia (71.4% vs. 36.4%, p = 0.001), and acidic urine (54.3% vs. 20.0%, p = 0.001) was higher in the malabsorptive group. Conversely, hyperuricosuria was more common in restrictive patients (29.1% vs. 11.4%, p = 0.049). No significant differences were observed for urine volume, sodium, phosphate, or calcium oxalate activity. IPTW-weighted logistic regression demonstrated that malabsorptive procedures were associated with significantly higher odds of hyperoxaluria (OR 2.95, 95% CI 1.03-8.44), hypocitraturia (OR 4.13, 95% CI 1.40-12.21), hypomagnesuria (OR 3.26, 95% CI 1.11-9.57), and acidic urine pH (OR 3.76, 95% CI 1.33-10.64). Malabsorptive bariatric surgery is associated with more lithogenic urinary profiles than restrictive surgery, particularly hyperoxaluria, hypocitraturia, hypomagnesuria, and acidic urine, underscoring increased risk of postoperative nephrolithiasis. Close monitoring of urinary parameters and multidisciplinary management are recommended to mitigate stone risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.